Subscribe
Subscribe

Tag: FDA Approval

Bicaval Valve Gains FDA Trial Approval.

Digital Health Transformation admin -
As of December 15, 2025, the medical technology landscape has witnessed a pivotal development with meaningful implications for cardiovascular...

Lungpacer Approval Marks Respiratory Care Breakthrough.

Hot This Week admin -
The medical device industry witnessed a transformative milestone on December 5, 2024, as Lungpacer Medical secured premarket approval from...

RapidAI FDA Clearance Expands AI Medical Platform.

Artificial Intelligence admin -
RapidAI Secures FDA Clearance for Five Advanced Medical AI Imaging Modules San Mateo-based medical artificial intelligence company RapidAI announced on...

Amgen Approval Boosts Lung Cancer Therapy.

Biotechnology admin -
Amgen Approval Signals New Momentum in Oncology Treatment Amgen Approval has become a central talking point across global biotechnology circles...

FDA Approval: At-Home Blood Pressure Device.

Hot This Week admin -
FDA Approves First-Ever At-Home Blood Pressure Monitoring Device for Hypertension ManagementIn a groundbreaking move, the U.S. Food and Drug...

Nitinotes Receives FDA Approval to Launch Pivotal U.S. Trial for EndoZip™ System EndoZip™ Aims to Transform Endoscopic Obesity Treatment.

Headlines News admin -
Caesarea, Israel – July 2025: Nitinotes has announced that it has received Investigational Device Exemption (IDE) approval from the...

AI Steps In: Clarity’s New Tool Seeks to Forecast Breast Cancer Risk with Accuracy.

Hot This Week admin -
A New Move in Breast Cancer Screening. (Clarity Mammography Risk Score) Breast cancer is still one of the most prevalent...

FDA Approves Vutrisiran to Treat ATTR-CM- New Treatment Seeks to Minimize Risks of Heart Failure in Patients.

Cardiovascular admin -
FDA approval Vutrisiran ATTR-CM treatment for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults This is a significant milestone...

Journey Medical Corporation Showcased Emrosi™ at 2025 American Academy of Dermatology Annual Meeting.

Dermatology admin -
Journey Medical Corporation (Nasdaq: DERM) exhibited at the 2025 American Academy of Dermatology (AAD) Annual Meeting. The event was...

© Medline Review 2026
a part of CIO Tech Insight LLC.